ArticleCureus2025
Hypokalemic Quadriparesis as the Initial Presentation of Sjögren's Syndrome With Distal Renal Tubular Acidosis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sjögren's Disease-Associated Renal Tubular Acidosis: An Integrated Immuno-Tubular Model of Tubular Dysfunction.International journal of medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 44-year-old woman with long-standing hypothyroidism presented with sudden-onset flaccid quadriparesis preceded by distal limb paresthesia, progressing rapidly to respiratory compromise requiring intubation. Laboratory evaluation revealed severe hypokalemia with non-anion gap metabolic acidosis, elevated transtubular potassium gradient, and inappropriately alkaline urine, consistent with distal renal tubular acidosis (dRTA). In the emergency, correction of electrolytes, intravenous bicarbonate therapy, and supportive management led to rapid neurological improvement. Following stabilization, further evaluation revealed positive antinuclear antibody (ANA) and anti-Ro/SSA, anti-La/SSB, and Ro52 antibodies, confirming Sjögren's syndrome. The patient had no prior sicca symptoms. This case highlights that hypokalemic paralysis can be the initial presentation of Sjögren's syndrome through dRTA, preceding classical exocrine features. Early recognition and correction of metabolic derangements are crucial for preventing morbidity and facilitating the diagnosis of underlying autoimmune pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.